WO2012097064A1 - Compositions nutritionnelles et procédés pour contrôler le glucose dans le sang - Google Patents

Compositions nutritionnelles et procédés pour contrôler le glucose dans le sang Download PDF

Info

Publication number
WO2012097064A1
WO2012097064A1 PCT/US2012/020941 US2012020941W WO2012097064A1 WO 2012097064 A1 WO2012097064 A1 WO 2012097064A1 US 2012020941 W US2012020941 W US 2012020941W WO 2012097064 A1 WO2012097064 A1 WO 2012097064A1
Authority
WO
WIPO (PCT)
Prior art keywords
beta
composition
prune extract
hmb
nutritional
Prior art date
Application number
PCT/US2012/020941
Other languages
English (en)
Inventor
Suzette L. Pereira
Paul W. Johns
Neile K. Edens
Catherine D. Johnson
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of WO2012097064A1 publication Critical patent/WO2012097064A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

L'invention concerne des compositions nutritionnelles et des procédés utilisant ces compositions pour traiter, prévenir, et lutter contre l'hyperglycémie et l'intolérance au glucose. Les compositions nutritionnelles comportent de l'extrait de prune et éventuellement du calcium HMB et sont efficaces en matière de contrôle des niveaux de glucose dans le sang. La combinaison de l'extrait de prune et du calcium HMB agit de manière synergétique dans le contrôle du glucose dans le sang.
PCT/US2012/020941 2011-01-13 2012-01-11 Compositions nutritionnelles et procédés pour contrôler le glucose dans le sang WO2012097064A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161432420P 2011-01-13 2011-01-13
US61/432,420 2011-01-13

Publications (1)

Publication Number Publication Date
WO2012097064A1 true WO2012097064A1 (fr) 2012-07-19

Family

ID=45525029

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/020941 WO2012097064A1 (fr) 2011-01-13 2012-01-11 Compositions nutritionnelles et procédés pour contrôler le glucose dans le sang

Country Status (1)

Country Link
WO (1) WO2012097064A1 (fr)

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013142424A1 (fr) * 2012-03-19 2013-09-26 Abbott Laboratories Acide bêta-hydroxy-bêta-méthylbutyrique pour améliorer la tolérance au glucose
US8648040B2 (en) 2005-03-21 2014-02-11 Abbott Laboratories Amino acid composition for improving glucose tolerance
EP2731599A1 (fr) * 2011-07-15 2014-05-21 Nusirt Sciences, Inc. Compositions et procédés de modulation de voies métaboliques
WO2014152606A2 (fr) * 2013-03-14 2014-09-25 Abbott Laboratories Traitement d'une insulinorésistance associée à une inactivité physique prolongée
WO2014179526A1 (fr) * 2013-05-01 2014-11-06 Abbott Laboratories Procédé pour améliorer la régénération de muscles âgés
WO2014186369A1 (fr) * 2013-05-15 2014-11-20 Abbott Laboratories Composition nutritionnelle comprenant une ou plusieurs anthocyanidines et méthodes correspondantes
US8916217B2 (en) 2010-01-29 2014-12-23 Abbott Laboratories Aseptically packaged nutritional liquids comprising HMB
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9198454B2 (en) 2012-03-08 2015-12-01 Nusirt Sciences, Inc. Compositions, methods, and kits for regulating energy metabolism
US9233204B2 (en) 2014-01-31 2016-01-12 Aseko, Inc. Insulin management
US9241508B2 (en) 2010-01-29 2016-01-26 Abbott Laboratories Nutritional emulsions comprising calcium HMB
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US9521859B2 (en) 2010-06-10 2016-12-20 Normanella T. Dewille Substantially clear nutritional liquids comprising calcium HMB and soluble protein
US20170119708A1 (en) * 2015-10-29 2017-05-04 Core Intellectual Properties Holdings, Llc Methods and compositions for modulating muscle and bone loss
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
US9707213B2 (en) 2013-03-15 2017-07-18 Nusirt Sciences, Inc. Compositions, methods and kits for reducing lipid levels
US9724319B2 (en) 2014-02-27 2017-08-08 Nusirt Sciences, Inc. Compositions and methods for the reduction or prevention of hepatic steatosis
US9886556B2 (en) 2015-08-20 2018-02-06 Aseko, Inc. Diabetes management therapy advisor
US9892234B2 (en) 2014-10-27 2018-02-13 Aseko, Inc. Subcutaneous outpatient management
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
US9943517B2 (en) 2012-11-13 2018-04-17 Nusirt Sciences, Inc. Compositions and methods for increasing energy metabolism
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000015174A2 (fr) * 1998-09-15 2000-03-23 Korea Institute Of Science And Technology Bioflavonoide utilise en tant qu'agent permettant d'abaisser le taux de glycemie
US20060024385A1 (en) * 2004-07-27 2006-02-02 Pedersen Mark A Metabolic capacity enhancing compositions and methods for use in a mammal
US20070219146A1 (en) * 2006-02-06 2007-09-20 Sunil Bhaskaran Synergistic Pharmaceutical And/Or Neutraceutical Flavanoid Composition For Management Of Diabetes Mellitus
WO2008115723A1 (fr) * 2007-03-19 2008-09-25 Atm Metabolics Lllp Composition et procédé pour le traitement du diabète et de perturbations du métabolisme
JP2009155336A (ja) * 2009-03-31 2009-07-16 Tsujido Chemical Corp 治療剤
US20100074969A1 (en) * 2008-09-19 2010-03-25 Unicity International, Inc. Method of controlling blood sugar levels, insulin levels, cholesterol levels, body fat levels, and body weight by administering a nutrient fiber matrix

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000015174A2 (fr) * 1998-09-15 2000-03-23 Korea Institute Of Science And Technology Bioflavonoide utilise en tant qu'agent permettant d'abaisser le taux de glycemie
US20060024385A1 (en) * 2004-07-27 2006-02-02 Pedersen Mark A Metabolic capacity enhancing compositions and methods for use in a mammal
US20070219146A1 (en) * 2006-02-06 2007-09-20 Sunil Bhaskaran Synergistic Pharmaceutical And/Or Neutraceutical Flavanoid Composition For Management Of Diabetes Mellitus
WO2008115723A1 (fr) * 2007-03-19 2008-09-25 Atm Metabolics Lllp Composition et procédé pour le traitement du diabète et de perturbations du métabolisme
US20100074969A1 (en) * 2008-09-19 2010-03-25 Unicity International, Inc. Method of controlling blood sugar levels, insulin levels, cholesterol levels, body fat levels, and body weight by administering a nutrient fiber matrix
JP2009155336A (ja) * 2009-03-31 2009-07-16 Tsujido Chemical Corp 治療剤

Cited By (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8648040B2 (en) 2005-03-21 2014-02-11 Abbott Laboratories Amino acid composition for improving glucose tolerance
US8916217B2 (en) 2010-01-29 2014-12-23 Abbott Laboratories Aseptically packaged nutritional liquids comprising HMB
US9241508B2 (en) 2010-01-29 2016-01-26 Abbott Laboratories Nutritional emulsions comprising calcium HMB
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
US9521859B2 (en) 2010-06-10 2016-12-20 Normanella T. Dewille Substantially clear nutritional liquids comprising calcium HMB and soluble protein
US9072692B2 (en) 2011-07-15 2015-07-07 Nusirt Sciences, Inc. Compositions and methods for modulating metabolic pathways
US9198883B1 (en) 2011-07-15 2015-12-01 Nusirt Sciences, Inc. Compositions and methods for modulating metabolic pathways
US9682053B2 (en) 2011-07-15 2017-06-20 Nusirt Sciences, Inc. Compositions and methods for modulating metabolic pathways
US9855235B2 (en) 2011-07-15 2018-01-02 Nusirt Sciences, Inc. Compositions and methods for modulating metabolic pathways
EP2731599A4 (fr) * 2011-07-15 2015-04-08 Nusirt Sciences Inc Compositions et procédés de modulation de voies métaboliques
US9351967B2 (en) 2011-07-15 2016-05-31 Nusirt Sciences, Inc. Compositions and methods for modulating metabolic pathways
JP2014520864A (ja) * 2011-07-15 2014-08-25 ニューサート サイエンシーズ， インコーポレイテッド 代謝経路を変調させるための組成物および方法
US10076507B1 (en) 2011-07-15 2018-09-18 Nusirt Sciences, Inc. Compositions and methods for modulating metabolic pathways
EP2731599A1 (fr) * 2011-07-15 2014-05-21 Nusirt Sciences, Inc. Compositions et procédés de modulation de voies métaboliques
US10383837B2 (en) 2011-07-15 2019-08-20 Nusirt Sciences, Inc. Compositions and methods for modulating metabolic pathways
US9713609B2 (en) 2012-03-08 2017-07-25 Nusirt Sciences, Inc. Compositions, methods, and kits for regulating energy metabolism
US9901573B2 (en) 2012-03-08 2018-02-27 Nusirt Sciences, Inc. Compositions, methods, and kits for regulating energy metabolism
US9198454B2 (en) 2012-03-08 2015-12-01 Nusirt Sciences, Inc. Compositions, methods, and kits for regulating energy metabolism
US9408410B2 (en) 2012-03-08 2016-08-09 Nusirt Sciences, Inc. Compositions, methods, and kits for regulating energy metabolism
WO2013142424A1 (fr) * 2012-03-19 2013-09-26 Abbott Laboratories Acide bêta-hydroxy-bêta-méthylbutyrique pour améliorer la tolérance au glucose
US10410740B2 (en) 2012-09-11 2019-09-10 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9483619B2 (en) 2012-09-11 2016-11-01 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9965596B2 (en) 2012-09-11 2018-05-08 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US10102922B2 (en) 2012-09-11 2018-10-16 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
US10629294B2 (en) 2012-09-11 2020-04-21 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US11131643B2 (en) 2012-09-11 2021-09-28 Aseko, Inc. Method and system for optimizing insulin dosages for diabetic subjects
US11733196B2 (en) 2012-09-11 2023-08-22 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
US9811638B2 (en) 2012-09-11 2017-11-07 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9773096B2 (en) 2012-09-11 2017-09-26 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US10646489B2 (en) 2012-11-13 2020-05-12 Nusirt Sciences, Inc. Compositions and methods for increasing energy metabolism
US9943517B2 (en) 2012-11-13 2018-04-17 Nusirt Sciences, Inc. Compositions and methods for increasing energy metabolism
WO2014152606A2 (fr) * 2013-03-14 2014-09-25 Abbott Laboratories Traitement d'une insulinorésistance associée à une inactivité physique prolongée
WO2014152606A3 (fr) * 2013-03-14 2015-02-05 Abbott Laboratories Traitement d'une insulinorésistance associée à une inactivité physique prolongée
CN105188695A (zh) * 2013-03-14 2015-12-23 雅培制药有限公司 与长期体力活动不足有关的胰岛素抗性的治疗
JP2016513701A (ja) * 2013-03-14 2016-05-16 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ 長期身体不活動に関連するインスリン抵抗性の治療
US9895357B2 (en) 2013-03-15 2018-02-20 Nusirt Sciences, Inc. Compositions, methods and kits for reducing lipid levels
US9707213B2 (en) 2013-03-15 2017-07-18 Nusirt Sciences, Inc. Compositions, methods and kits for reducing lipid levels
WO2014179526A1 (fr) * 2013-05-01 2014-11-06 Abbott Laboratories Procédé pour améliorer la régénération de muscles âgés
CN105188413A (zh) * 2013-05-01 2015-12-23 雅培公司 增强老化肌肉再生的方法
WO2014186369A1 (fr) * 2013-05-15 2014-11-20 Abbott Laboratories Composition nutritionnelle comprenant une ou plusieurs anthocyanidines et méthodes correspondantes
US9504789B2 (en) 2014-01-31 2016-11-29 Aseko, Inc. Insulin management
US11490837B2 (en) 2014-01-31 2022-11-08 Aseko, Inc. Insulin management
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
US9965595B2 (en) 2014-01-31 2018-05-08 Aseko, Inc. Insulin management
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US9604002B2 (en) 2014-01-31 2017-03-28 Aseko, Inc. Insulin management
US9233204B2 (en) 2014-01-31 2016-01-12 Aseko, Inc. Insulin management
US11857314B2 (en) 2014-01-31 2024-01-02 Aseko, Inc. Insulin management
US10255992B2 (en) 2014-01-31 2019-04-09 Aseko, Inc. Insulin management
US11804300B2 (en) 2014-01-31 2023-10-31 Aseko, Inc. Insulin management
US11783946B2 (en) 2014-01-31 2023-10-10 Aseko, Inc. Method and system for insulin bolus management
US11783945B2 (en) 2014-01-31 2023-10-10 Aseko, Inc. Method and system for insulin infusion rate management
US9892235B2 (en) 2014-01-31 2018-02-13 Aseko, Inc. Insulin management
US10453568B2 (en) 2014-01-31 2019-10-22 Aseko, Inc. Method for managing administration of insulin
US10535426B2 (en) 2014-01-31 2020-01-14 Aseko, Inc. Insulin management
US9710611B2 (en) 2014-01-31 2017-07-18 Aseko, Inc. Insulin management
US11621074B2 (en) 2014-01-31 2023-04-04 Aseko, Inc. Insulin management
US10811133B2 (en) 2014-01-31 2020-10-20 Aseko, Inc. System for administering insulin boluses to a patient
US11468987B2 (en) 2014-01-31 2022-10-11 Aseko, Inc. Insulin management
US11081233B2 (en) 2014-01-31 2021-08-03 Aseko, Inc. Insulin management
US11311213B2 (en) 2014-01-31 2022-04-26 Aseko, Inc. Insulin management
US11158424B2 (en) 2014-01-31 2021-10-26 Aseko, Inc. Insulin management
US9724319B2 (en) 2014-02-27 2017-08-08 Nusirt Sciences, Inc. Compositions and methods for the reduction or prevention of hepatic steatosis
US9872844B2 (en) 2014-02-27 2018-01-23 Nusirt Sciences, Inc. Compositions and methods for the reduction or prevention of hepatic steatosis
US11678800B2 (en) 2014-10-27 2023-06-20 Aseko, Inc. Subcutaneous outpatient management
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
US11694785B2 (en) 2014-10-27 2023-07-04 Aseko, Inc. Method and dosing controller for subcutaneous outpatient management
US10403397B2 (en) 2014-10-27 2019-09-03 Aseko, Inc. Subcutaneous outpatient management
US9892234B2 (en) 2014-10-27 2018-02-13 Aseko, Inc. Subcutaneous outpatient management
US10128002B2 (en) 2014-10-27 2018-11-13 Aseko, Inc. Subcutaneous outpatient management
US11574742B2 (en) 2015-08-20 2023-02-07 Aseko, Inc. Diabetes management therapy advisor
US9886556B2 (en) 2015-08-20 2018-02-06 Aseko, Inc. Diabetes management therapy advisor
US10380328B2 (en) 2015-08-20 2019-08-13 Aseko, Inc. Diabetes management therapy advisor
US11103001B2 (en) * 2015-10-29 2021-08-31 Core Intellectual Properties Holdings, Llc Methods and compositions for modulating muscle and bone loss
US20170119708A1 (en) * 2015-10-29 2017-05-04 Core Intellectual Properties Holdings, Llc Methods and compositions for modulating muscle and bone loss

Similar Documents

Publication Publication Date Title
WO2012097064A1 (fr) Compositions nutritionnelles et procédés pour contrôler le glucose dans le sang
WO2012097061A1 (fr) Compositions nutritionnelles et procédés pour améliorer le métabolisme protéique des muscles squelettiques
EP1773364B1 (fr) Compositions nutritives et procedes pour traiter ou prevenir l'osteoporose
US20210274825A1 (en) Low calorie nutritional compositions for maintaining metabolic balance
US7435431B2 (en) Method for controlling body weight in estrogen-insufficient women
US20220125093A1 (en) Nutritional supplements including meal replacements and related methods
JP5965916B2 (ja) キウイフルーツ由来の心保護剤
WO2013148685A1 (fr) Compositions nutritionnelles à base de protéine de pois
US20150025143A1 (en) Beta-hydroxy-beta-methylbutyric acid for improving glucose tolerance
MX2014001830A (es) Metodo para transformar un alimento.
WO2002062329A1 (fr) Compositions thérapeutiques et nutritionnelles renfermant de l'acide pyruvique et de la glutamine, possédant une activité antioxydante et étant capables de réguler une surcharge pondérale
JP4022350B2 (ja) コレステロール上昇抑制作用およびｈｄｌ−コレステロール低下抑制作用を有する組成物
US7601370B2 (en) Method for controlling body weight in estrogen-insufficient women
US20150238447A1 (en) Beta-hydroxy-beta-methylbutryic acid-containing compositions and uses thereof
AU2011265567A1 (en) Nutritional compositions and methods for treating or preventing osteoporosis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12700911

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12700911

Country of ref document: EP

Kind code of ref document: A1